Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study

H Ip, T Amer, M Dangoor, A Zamir… - JRSM Short …, 2012 - journals.sagepub.com
Objectives England's National Health Service (NHS) introduced a 62-day target, from
referral to treatment, to make lung cancer patient pathways more efficient. This study aims to …

Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?

S Pozzi, A Scomparin, SI Dangoor, DR Ajamil… - Advanced Drug Delivery …, 2021 - Elsevier
The complexity and diversity of the biochemical processes that occur during tumorigenesis
and metastasis are frequently over-simplified in the traditional in vitro cell cultures. Two-…

Targeting glioblastoma: Advances in drug delivery and novel therapeutic approaches

…, S Koshrovski‐Michael, SI Dangoor… - Advanced …, 2021 - Wiley Online Library
Glioblastoma (GB) is the most lethal type of primary tumor in the central nervous system.
Current treatments include surgical resection followed by chemotherapy and radiotherapy. With …

Recent progress in polymer therapeutics as nanomedicines

SI Dangoor, SK Michael, H Baabur-Cohen… - Handbook of …, 2021 - taylorfrancis.com
The term Polymer Therapeutics is defined as water-soluble biocompatible polymers that can
function as bioactive nanomedicines, or as nanocarriers conjugated with therapeutic agents…

Managing patient pathways to achieve lung cancer waiting time targets: A mixed method study: 0362

H Ip, T Amer, M Dangoor, A Zamir… - … Journal of Surgery, 2011 - journals.lww.com
Background: The NHS introduced the 62-day target to make lung cancer pathways more
efficient. This study aims to understand pathway delays which contribute to breaches of the …

[HTML][HTML] Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

…, Q Campbell-Hewson, R Cubedo, A Dangoor… - The lancet …, 2019 - thelancet.com
Background Alveolar soft-part sarcoma (ASPS) is a rare soft-tissue sarcoma that is unresponsive
to chemotherapy. Cediranib, a tyrosine-kinase inhibitor, has shown substantial activity …

Expression of the 5T4 Oncofoetal Antigen in Renal Cell Carcinoma: A Potential Target for T-Cell Based Immunotherapy

RW Griffiths, A Dangoor, DE Gilham… - Journal of …, 2005 - journals.lww.com
… Expression of TRAIL on Activated Human NK Cells Contributes to Cytotoxicity Against
Human Neuroblastoma Cell Lines Michael A. Sheard1, Hong-wei Wu1, Shahab Asgharzadeh1, …

An Autopsy Series of Seven Cases of VPS13A Disease (Chorea‐Acanthocytosis)

…, KJ Lind‐Watson, EL Thorn, DK Dangoor… - Movement …, 2023 - Wiley Online Library
Background Vacuolar protein sorting 13 homolog A (VPS13A) disease, historically known as
chorea‐acanthocytosis, is a rare neurodegenerative disorder caused by biallelic mutations …

Folates, folic acid and preconception care–a review

SH House, JAA Nichols, S Rae - JRSM open, 2021 - journals.sagepub.com
The link between folate deficiency and congenital spina bifida defects was first suggested in
the 1960s. Although the prevention of these defects by preconception folic acid …

[HTML][HTML] An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients

…, D Cunningham, R Coleman, A Dangoor… - …, 2016 - ncbi.nlm.nih.gov
… , 1, 2, 3, 14 Roshan Agarwal, 1, 15 Samreen Ahmed, 1, 16 Caroline Archer, 1, 17 Ruth Board,
1, 18 Judith Carser, 1, 19 Ellen Copson, 3, 45 David Cunningham, 1, 3, 20 Rob Coleman, 1, 32 …